Pharsight Corp.

Less than two months after Genomica Corp. announced a change in strategic direction, resulting from disappointing market penetration of its third-party enterprise bioinformatics software, the compa

Quintiles' significant investment in web technology, at a time when its earnings are hurting, represents a calculated gamble that it can capture the margin growth opportunity left to it—re-engineering

When is an active molecule a good drug? Companies are developing new screening tools to help them select drug-like candidates early in the drug discovery process. by Mary Stuart Structural design indu

Quintiles Transnational Corp. 's recent announcement that it anticipated lower-than-expected operating earnings for the first half of 2000 was just the latest in a year-long string of bad news for t